# PredOmix

Source: https://onco.cc/companies/predomix/  
OnCo record `predomix` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An Indian company with a Singapore affiliate that develops OncoVeryx, a serum metabolomics blood test it reports can detect 30 cancers.

## Summary

PredOmix Technologies Private Limited, Gurugram, and PredOmix Health Sciences, Singapore, according to their authors' affiliations, combine untargeted serum metabolomics with machine learning. Its employees have published versions of the test for four, fifteen and thirty cancers, the last in an investigator-initiated trial with HCG cancer centres (CTRI/2023/03/050316).

## Fields

- Kind: Company
- Last checked: 2026-11-03
- Also known as: PredOmix Technologies; PredOmix Health Sciences
- HQ: Gurugram
- Type: diagnostics

## Sources

- Nagarkar et al., Cancer Reports 2024: https://doi.org/10.1002/cnr2.70042

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Early Detection & Screening](https://onco.cc/fronts/early-detection/)
- technologies: [Liquid biopsy (ctDNA)](https://onco.cc/technologies/liquid-biopsy/), [Multi-cancer early detection (MCED)](https://onco.cc/technologies/mced/)
- drugs: [OncoVeryx (PredOmix)](https://onco.cc/drugs/oncoveryx/)
- key papers: [Development of a Serum Metabolome-Based Test for Early-Stage Detection of Multiple Cancers](https://onco.cc/key-papers/paper-predomix-metabolome-cancer-rep-2024/)

---
JSON: https://onco.cc/api/v1/entities/predomix.json